←
Pietro Genovese62 posts
Pietro Genovese avatar

Pietro Genovese

@Genovese_Lab

Faculty at Dana Farber / Boston Children’s @DFBC_PedCare. Advanced genetic engineering of hematopoiesis Lab.

◷ Joined April 2019▧ 3 Photos and videos
Genetic Engineering & Biotechnology News avatar
⟳ Pietro Genovese retweeted
Genetic Engineering & Biotechnology News@GENbio·Jul 9

Epitope Editing Strategy Could Enable Less Toxic Stem Cell Transplants Ability to avoid pretransplant chemotherapy could open up #stemcelltransplants for patients who might otherwise be too sick or too high risk @Genovese_Lab @DanaFarber #epitopeediting hubs.li/Q04p1s5p0

Pietro Genovese avatar
Pietro Genovese@Genovese_Lab·29 May 2024

Thrilled to see the great work from @danielevanbauer lab featured in @NatureBiotech! The discovery that a limited nucleotide pool in HSPCs constrains prime editing is a leap forward in gene editing technology. A huge shoutout to @SbastienLevesq4 and the entire team!

My postdoc work in the @danielevanbauer lab is out @NatureBiotech! We found that the limited nucleotide pool in hematopoietic stem and progenitor cells (HSPCs) constrains reverse transcription and thus prime editing (PE). nature.com/articles/s41587-0…

Sébastien Levesque avatar
⟳ Pietro Genovese retweeted
Sébastien Levesque@SbastienLevesq4·28 May 2024

My postdoc work in the @danielevanbauer lab is out @NatureBiotech! We found that the limited nucleotide pool in hematopoietic stem and progenitor cells (HSPCs) constrains reverse transcription and thus prime editing (PE). nature.com/articles/s41587-0…

Pietro Genovese avatar
Pietro Genovese@Genovese_Lab·28 Oct 2023

Very proud of your achievements @ferrari_sam93 !! It has been a privilege contributing in mentoring such amazing young scientist!

I am deeply honored to receive the 2023 Early Career Investigator Award by @ESGCT at the Annual Congress in Brussels together with @alessionahmad. This prestigious recognition would not have been possible without my SR-Tiget colleagues and mentors @NaldiniLab and @Genovese_Lab.

Post attachment
Pietro Genovese avatar
Pietro Genovese@Genovese_Lab·30 Aug 2023

Excited to share our latest publication about epitope editing in hematopoietic stem cells to enable targeted immunotherapy for acute myeloid leukemia. Congrats to @CasiratiG and all collaborators for this amazing work. nature.com/articles/s41586-0…

I'm thrilled to announce that our work, 'Epitope Editing Enables Targeted Immunotherapy of Acute Myeloid Leukemia,' is out today in Nature journal! Link: nature.com/articles/s41586-0… doi: doi.org/10.1038/s41586-023-0…

Post attachment
ASGCT avatar
⟳ Pietro Genovese retweeted
ASGCT@ASGCTherapy·14 Dec 2022

With #geneediting, researchers restored levels of CTLA-4 in T cells from patients with CTLA-4 insufficiency. In mice, they improved symptoms. ASGCT members involved: @RealDrfox, MbChB, PhD; Claire Booth, MBBS, PhD; Pietro Genovese @Genovese_Lab, PhD: ucl.ac.uk/news/2022/oct/new-….

Valentina Vavassori avatar
⟳ Pietro Genovese retweeted
Valentina Vavassori@ValentinaVavas2·18 Aug 2022

These are exciting but hard times for #genetherapy . It’s heartbreaking to witness withdrawal of effective gene therapies from the market. They are often the only cure for many rare conditions, saving lives of other human beings. Don’t miss this!

Ensuring a future for gene therapy for rare diseases. Comment from Alessandro Aiuti @francescapasi and @NaldiniLab San Raffaele Telethon Institute of Gene Therapy, Italy nature.com/articles/s41591-0…